Document is current

Any future updates will be listed below

T-DXd effective as second-line therapy in G/GEJ cancers

Crossref DOI link: https://doi.org/10.1038/s41571-025-01044-8

Published Online: 2025-06-12

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark